Book a free demo with us
Book Now
Evogene
Evogene (NASDAQ:EVGN, TASE: EVGN.TA) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform.
Total Fundraised$5B
PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
2022
Rehovot, Israel
ISR
Agriculture
Agribusiness
Genetic
Biotechnology
- 
https://evogene.com/Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
Evogene's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Related Startups
Social Media
© 2024 Lucidity Insights.
